How e-pharmacies are living but still on the edge - podcast episode cover

How e-pharmacies are living but still on the edge

Apr 23, 202312 minEp. 58
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Ever since they came up a little less than a decade ago, e-pharmacies have been fighting a constant battle. On one hand there is the severe pushback from traditional pharmacy lobbies and on the other, the lack of a regulatory mechanism.

It was only in 2017 that the government officially acknowledged their existence. It was a small win, but a win nonetheless. But the draft e-pharmacy rules that the government came up with a year later were never notified.

Despite this, e-pharmacies continued operating and their importance was only highlighted further during the pandemic.

But in February this year, the Central Drugs Standard Control Organisation (CDSCO) sent show-cause notices to 20 e-pharmacies. These included Tata 1mg, Amazon, Flipkart, Reliance Retail-owned NetMeds, MediBuddy, Practo and Apollo.

However, e-pharmacies are here to stay.

Tune in to find out more

For the best experience, listen in Metacast app for iOS or Android